Sign up to save your podcasts
Or
Share Insights from RESHAPE-HF2 Trial | ESC 2024
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Insights from RESHAPE-HF2 Trial | ESC 2024
Aakriti Gupta, MD, FACC, JACC Executive Associate Editor, and Stefan D. Anker, MD, discuss the insights from the RESHAPE-HF2 trial - an eight-year study on the efficacy of transcatheter edge-to-edge repair for mitral valve regurgitation in patients with heart failure.
View all episodes
By American College of Cardiology
4.2
162162 ratings
Aakriti Gupta, MD, FACC, JACC Executive Associate Editor, and Stefan D. Anker, MD, discuss the insights from the RESHAPE-HF2 trial - an eight-year study on the efficacy of transcatheter edge-to-edge repair for mitral valve regurgitation in patients with heart failure.
More shows like JACC This Week
View all
JAMA Editors' Summary
134 Listeners
NEJM This Week
321 Listeners
JAMA Clinical Reviews
504 Listeners
This Week in Cardiology
906 Listeners
JACC Specialty Journals
21 Listeners
Circulation on the Run
31 Listeners
The Curbsiders Internal Medicine Podcast
3,374 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
138 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
65 Listeners
ACC CardiaCast
39 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
94 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Cardionerds: A Cardiology Podcast
437 Listeners